论文信息 - An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in patients with relapsed gastric cancer. - 字舞流文

An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in patients with relapsed gastric cancer.

Y. Bang | S. Domchek | B. Kaufman | S. Hong | T. Evans | J. S. Lee | H. Angell | R. Geva | S. Stemmer | M. Lanasa | M. Tang | P. Herbolsheimer | C. Gresty | M. Lanasa | C. Gresty | L Opincar | P. Herbolsheimer | J. Lee